Jones Financial Companies
RVMD icon

Jones Financial Companies’s Revolution Medicines RVMD Stock Holding History

Jones Financial Companies’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.62M Buy
19,900
+19,474
+4,571% +$2.84M ﹤0.01% 1332
2026
Q1 		$39.4K Buy
426
+218
+105% +$22K ﹤0.01% 3032
2025
Q4 		$16.6K Buy
208
+162
+352% +$10.6K ﹤0.01% 3017
2025
Q3 		$2.02K Hold
46
– – ﹤0.01% 3690
2025
Q2 		$1.7K Sell
46
-107
-70% -$4.11K ﹤0.01% 3520
2025
Q1 		$5.71K Buy
+153
New +$6.21K ﹤0.01% 2914

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Jones Financial Companies's RVMD Position: Q2 2026 in Review

Jones Financial Companies increased its Revolution Medicines (RVMD) stake by 4,571% in Q2 2026, buying an estimated $2.84M and bringing the position to 19,900 shares worth $3.62M. The position accounts for ﹤0.01% of the portfolio, ranked #1332.

Jones Financial Companies first reported a position in RVMD in Q1 2025 and has held it in 6 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Jones Financial Companies held 19,900 shares of Revolution Medicines worth $3.62M as of Q2 2026.
  • Jones Financial Companies bought 19,474 Revolution Medicines shares in Q2 2026, an estimated $2.84M.
  • Revolution Medicines made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #1332 holding.
  • Jones Financial Companies first reported a position in Revolution Medicines in Q1 2025 and has held it in 6 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.